Searched for
PERTUZUMAB BRAZIL
Biocon shares: Active Pine may divest up to 1% equity worth Rs 638 crore via block dealActive Pine is likely to sell up to 1.66 crore Biocon shares, worth Rs 638 crore, through a block deal at Rs 385 per share. The development...- Sun Pharma gets ratings boost from Moody's, S&P over USD 11.75-bn Organon & Co acquisition bidRating agencies Moody's and S&P assigned investment-grade ratings to Sun Pharmaceutical Industries. This action follows Sun Pharma's propos...
- Biocon shares rise 2% on 10-year Pertuzumab supply deal for breast cancer therapy in BrazilBiocon shares rose after the company secured a 10-year Pertuzumab supply contract in Brazil. The consortium with Bahiafarma and Bionovis re...
- Biocon signs 10-year Brazil supply deal for Pertuzumab breast cancer drugIn a significant move, Biocon has secured a ten-year contract in Brazil for the distribution of Pertuzumab, made possible through its colla...
- BahiaFarma, Biocon, Bionovis inks MoU in pharma sectorIndia and Brazil signed multiple Memoranda of Understanding (MoUs) during Brazilian President Lula da Silva's visit. Key agreements include...
- New GST rates from today, September 22: Check the full list to see what’s cheaper and what’s costlierNew GST Rates Full List: India's revised GST structure, effective today, reduces taxes on nearly 400 goods and services, including food, au...
- GST Rate Changes 2025: Check full list of items with revised rates effective from Navratri, September 22GST Rates List 2025: The GST Council has announced tax slab revisions impacting almost all goods and services. After the rationalisation of...
Load More